Figure 2

Prognosis of GC patients who underwent curative surgery. Patients were categorized into two groups according to the extent of lymphadenectomy: “D2 plus” group and D2 group. (A) Survival curve for all patients: the 5-year OS rates were 55.3% and 41.2% for “D2plus” group and D2 group, respectively (P = 0.006). (B) Survival curve for matched patients: the 5-year OS rates were 55.3% and 43.9% for “D2 plus” group and D2 group, respectively (P = 0.042).